Last reviewed · How we verify

NCT05924828

sTREM-1, sTREM-2, Presepsin, and Periodontitis

Completed Last updated 30 January 2024
What this trial tests

trial testing no intervention in Periodontal Diseases in 60 participants. Completed in 1 December 2023.

Timeline
1 August 2023
Primary endpoint
1 October 2023
1 December 2023

Quick facts

Lead sponsorAtaturk University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date1 August 2023
Primary completion1 October 2023
Estimated completion1 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

Adults 18 to 65, any sex, with Periodontal Diseases or Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to compare saliva sTREM-1, sTREM-2, Presepsin levels and sTREM-1/sTREM-2 ratio of participants with/without periodontitis. The main question it aims to answer is there a relationship between saliva sTREM-1, sTREM-2, Presepsin levels, sTREM-1/sTREM-2 ratio and periodontitis. Participants will give saliva samples without any intervention

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Periodontal Diseases

Currently open trials in the same condition.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05924828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing